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Conclusions: Moddicom will be freely available for the 
community in the next spring. Hopefully the use of this tool 
will allow to share (and tune) a large set of functions 
available for modeling purposes in the scientific community. 
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Purpose/Objective: The bowel may display complex motion 
patterns during RT. This is a likely contributor to the 
relatively weak relations between bowel doses and toxicity. 
To enable studies of motion-inclusive dose response relations 
of the bowel, contour propagation methods may play an 
important role as a supplement or possibly an alternative to 
manual delineation. This study aimed to assess the inter-
observer variations in contouring bowel loops (BLs) as well as 
their impact on dose/volume parameters, as a benchmark for 
comparison with the performance of a commercial contour 
propagation software. 
Materials and Methods: Four observers contoured BLs on 
both the planning kV-CT (kV-BLs) and on a therapy MV-CT 
(MV-BLs) in eight patients treated with helical tomotherapy. 
After elastic registration, the kV-BLs were also propagated 
(CP-BLs) to the MV-CT by using a commercial software 
(MimVista). Subsequently these propagated contours were 
manually corrected (MC-BLs). The inter-observer variations 
and agreement between both CP-BLs and MC-BLs relative to 
the MV-BLs were quantified using the DICE index. Contouring 
time was also compared. To evaluate the impact of 
inter/intra-observer variations on DVH parameters, a 
tomotherapy plan was simulated for each patient (60 Gy to 
prostate and seminal vesicles, 52.5 Gy to lymph nodes); 
absolute and relative DVHs were compared (V10-V50Gy). 
Finally, to further evaluate BL propagation on MV-CTs, results 
were compared against BL propagation to kV-CTs by 
repeating the same procedure on two additional patients 
with both planning kV-CT and therapy kV-CT available. 
Results: The mean DICE index between the observers were 
0.89 for kV-BLs, 0.82 for MV-BLs and 0.92 for the reference 
therapy kV-CT, with significant inter-modality differences 
(Wilcoxon test, p<0.002). Contour propagation alone 
generally failed, with an average DICE between propagated 
and manual BLs on MV-CTs/kV-CTs of 0.56/0.65, missing a 
large part of the BL volume due to the poor local contrast 
between BLs and pelvic fat and the difficulties of recognising 
changes in air content between different images. After 
manual correction, DICE values were satisfactory, increasing 
to 0.81 for MV-CTs and 0.90 for kV-CT while reducing 
contouring time with on average 48%. Regarding the impact 
on DVHs, significant differences (p<0.05) were found 
between CP-BLs and manual BLs for absolute (V10-V50) but 
not for relative volumes, while a very good agreement was 
generally found for MC-BLs. 
 
 
 
Conclusions: The visibility of the bowel on MV-CT was 
reasonably good in most of the pelvic cavity indicating that 
MV-CTs has potential for quantifying bowel motion during RT. 
Inter-observer variation was satisfactory although lower than 
in kV-CT. The use of commercial software to propagate bowel 
contours from kV-CT to MV-CT followed by manual correction 
does not influence the resulting DVHs for the bowel loops and 
may replace full manual contouring.  
Work partially supported by a research grant Accuray. 
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Purpose/Objective: A lot of effort is put into diminishing the 
CTV-PTV margin in order to spare normal structures adjacent 
to PTV. The purpose of this work was to test the hypothesis 
that the mean dose distribution calculated from a few first 
fractions is a good estimate of the cumulated dose 
distribution, representing the whole treatment. 
Materials and Methods: For 25 patients with prostate cancer 
treated in our clinic orthogonal portal images were taken 
daily during the entire treatment (25 fractions, 2.6Gy 
fraction dose). Set-up errors in three directions were 
recorded. For each patient three treatment plans were 
prepared: 3D-CRT, 5 fields IMRT plan and two arcs VMAT. For 
each treatment technique and each fraction the dose 
